Study Type
Pragmatic Clinical Trial - vanguard phase
The TheRAPy vanguard is a pragmatic, multicentre, cluster-randomized, crossover trial that will determine the feasibility of studying whether an institutional policy of routine use of autologous priming reduces red blood cell transfusion up to 72 hours after cardiac surgery when compared with a policy of crystalloid priming.
Learn More about TheRAPYPragmatic Clinical Trial - vanguard phase
Multicentre, cluster-randomized, crossover trial - vanguard phase
1
4
4,500
2024-2026
PHRI
Back To Top